159 related articles for article (PubMed ID: 36760254)
1. Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients.
Chai N; Xie P; Chen H; Li Y; Zhao Y; He J; Zhang H
Ann Transl Med; 2023 Jan; 11(1):14. PubMed ID: 36760254
[TBL] [Abstract][Full Text] [Related]
2. ADAMDEC1 accelerates GBM progression
Qi H; Wang P; Sun H; Li X; Hao X; Tian W; Yu L; Tang J; Dong J; Wang H
Front Oncol; 2022; 12():945025. PubMed ID: 36172139
[TBL] [Abstract][Full Text] [Related]
3. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
[TBL] [Abstract][Full Text] [Related]
4. Identification of chemoresistance-associated miRNAs in breast cancer.
Lou W; Liu J; Ding B; Xu L; Fan W
Cancer Manag Res; 2018; 10():4747-4757. PubMed ID: 30425571
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
Zhu W; Shi L; Gong Y; Zhuo L; Wang S; Chen S; Zhang B; Ke B
Thorac Cancer; 2022 Apr; 13(7):1027-1039. PubMed ID: 35178875
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
Chen H; Cheng S; Xiong W; Tan X
Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
[TBL] [Abstract][Full Text] [Related]
7. ADAM-like Decysin-1 (ADAMDEC1) is a positive regulator of Epithelial Defense Against Cancer (EDAC) that promotes apical extrusion of RasV12-transformed cells.
Yako Y; Hayashi T; Takeuchi Y; Ishibashi K; Kasai N; Sato N; Kuromiya K; Ishikawa S; Fujita Y
Sci Rep; 2018 Jun; 8(1):9639. PubMed ID: 29941981
[TBL] [Abstract][Full Text] [Related]
8. High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer.
Fu L; Wang Z; Jiang F; Wei G; Sun L; Guo C; Wu J; Zhu J
J Oncol; 2022; 2022():9342283. PubMed ID: 36157241
[TBL] [Abstract][Full Text] [Related]
9. The role of ADAM-like decysin 1 in non-eosinophilic chronic rhinosinusitis with nasal polyps.
Sugimoto N; Nakayama T; Kasai Y; Asaka D; Mitsuyoshi R; Tsurumoto T; Takaishi S; Omae S; Kojima H; Tanaka Y; Haruna SI
Acta Otolaryngol; 2018 Sep; 138(9):830-836. PubMed ID: 29936897
[TBL] [Abstract][Full Text] [Related]
10. Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation.
O'Shea NR; Chew TS; Dunne J; Marnane R; Nedjat-Shokouhi B; Smith PJ; Bloom SL; Smith AM; Segal AW
J Crohns Colitis; 2016 Dec; 10(12):1417-1427. PubMed ID: 27226416
[TBL] [Abstract][Full Text] [Related]
11. Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα
Ha SE; Jorgensen BG; Wei L; Jin B; Kim MS; Poudrier SM; Singh R; Bartlett A; Zogg H; Kim S; Baek G; Kurahashi M; Lee MY; Kim YS; Choi SC; Sasse KC; Rubin SJS; Gottfried-Blackmore A; Becker L; Habtezion A; Sanders KM; Ro S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563399
[TBL] [Abstract][Full Text] [Related]
12. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
Xu J; Liu L; Zheng X; You C; Li Q
Neurol Res; 2012 Sep; 34(7):701-6. PubMed ID: 22776555
[TBL] [Abstract][Full Text] [Related]
13. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12.
Bates EE; Fridman WH; Mueller CG
Immunogenetics; 2002 May; 54(2):96-105. PubMed ID: 12037602
[TBL] [Abstract][Full Text] [Related]
14. Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1.
Shi L; Li S; Maurer K; Zhang Z; Petri M; Sullivan KE
Mol Immunol; 2018 Nov; 103():312-321. PubMed ID: 30352365
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets.
Wu M; Shang X; Sun Y; Wu J; Liu G
PeerJ; 2020; 8():e8961. PubMed ID: 32419983
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive bioinformatics analysis of functional molecules in colorectal cancer.
Meng T; Lan Z; Zhao X; Niu L; Chen C; Zhang W
J Gastrointest Oncol; 2022 Feb; 13(1):231-245. PubMed ID: 35284121
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
[TBL] [Abstract][Full Text] [Related]
18. ADAMDEC1 promotes skin inflammation in rosacea via modulating the polarization of M1 macrophages.
Liu T; Deng Z; Xie H; Chen M; Xu S; Peng Q; Sha K; Xiao W; Zhao Z; Li J
Biochem Biophys Res Commun; 2020 Jan; 521(1):64-71. PubMed ID: 31627897
[TBL] [Abstract][Full Text] [Related]
19. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
Qattan A; Al-Tweigeri T; Alkhayal W; Suleman K; Tulbah A; Amer S
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918859
[TBL] [Abstract][Full Text] [Related]
20. ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.
Lund J; Olsen OH; Sørensen ES; Stennicke HR; Petersen HH; Overgaard MT
J Biol Chem; 2013 Jul; 288(29):21367-21375. PubMed ID: 23754285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
